Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC. Amezalpat builds ...

In an interview with Applied Clinical Trials Associate Editor Don Tracy, Richard Young, CEO, Cluepoints, offers his key ...

As genomic technologies become more accessible, they have the potential to reduce healthcare disparities and improve equity ...

Healthlion Medical Solutions and the LionHeart Family Institute have successfully concluded a 12-month nonpartisan research ...

The American Cancer Society is calling on the Trump administration to restore access to comprehensive scientific data.

Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly ...

In an interview with Applied Clinical Trials Associate Editor Don Tracy, Richard Young, CEO, CluePoints, discusses goals of the SCOPE Summit and CluePoints' evolving approach to risk detection.

The race is on to build a new generation of healthcare software to replace legacy hospital systems that in some cases may not ...

Max Schachter wanted to be close to his son Alex on his birthday, July 9, so he watched old videos of him. “It put a smile on ...